CAR-T cell therapies targeting encephalitogenic myeloid cells in neuroinflammation
Novel CAR-T cell platform designed to selectively eliminate disease-driving bone marrow-derived myeloid cells in the central nervous system. Based on proprietary transcriptomic and epigenomic signatures distinguishing pa...